MAGELLAN LONGEVITY
HomeNutraceuticals & Cellular Energizers › Carnosine

Carnosine

Written and medically reviewed by , physiatrist · Last reviewed · How we grade
In one paragraph

Carnosine — small, short RCTs and meta-analyses show modest glycemic improvements and a small delayed-recall benefit limited to specific memory domains. No long-term, aging, or lifespan outcomes have been tested, and several measured outcomes were null. Studied dose: 1–2 g/day.

Source: BMJ Open 2017, PMID 28864708 ↗ · Nutraceuticals & Cellular Energizers · How Magellan grades evidence · Study write-up · evidence confidence: high

Nutraceuticals & Cellular Energizers24 PubMed citations
$32.49 typical listed price — check the live price on Amazon
View Carnosine on Amazon ↗   Open in the Magellan store →

What it is

Carnosine (beta-alanyl-L-histidine) is a naturally occurring dipeptide, composed of the amino acids beta-alanine and L-histidine, that is highly concentrated in skeletal muscle, cardiac muscle, and the brain. It acts as an intracellular pH buffer and as an antioxidant and anti-glycating agent: it scavenges reactive oxygen and nitrogen species, chelates transition-metal ions, and traps reactive carbonyls such as methylglyoxal to inhibit formation of advanced glycation end-products (AGEs). Tissue carnosine can be raised by supplementing carnosine itself or its rate-limiting precursor beta-alanine, and endogenous levels tend to decline with age.

Its role in longevity

Meta-analyses of randomized trials indicate that carnosine or beta-alanine supplementation modestly improves glycemic control, lowering fasting glucose and HbA1c, in people with prediabetes or type 2 diabetes, and pooled trials of histidine-containing dipeptides also report reduced waist circumference and a small improvement in delayed verbal recall; smaller trials report reductions in circulating AGEs, triglycerides, inflammatory markers, and oxidative-stress and kidney-injury markers, and mechanistic and animal work links its anti-glycation activity to protection of proteins and even to lifespan in a model organism. The evidence base remains limited: human trials are generally small and short, several outcomes (musculoskeletal measures, AGEs in autism, some insulin measures) showed no benefit, effect sizes are modest, and one observational study found higher endogenous muscle carnosine associated with insulin resistance, underscoring that supplementation and native tissue levels are not equivalent. This evidence concerns the carnosine and beta-alanine compound and its mechanisms in human aging and metabolic health, not this specific commercial product.

The research

Peer-reviewed studies on the active compound — citations link to PubMed.

“carnosine preserves insulin sensitivity and secretion in overweight and obese individuals”
BMJ Open 2017 · PMID 28864708
“carnosine intervention reduced HbA1C levels in intervention vs control groups”
Complement Ther Med 2019 · PMID 31987255
“Our analysis indicated that supplementation significantly reduced fasting blood glucose (FBG) (SMD: -0.53; 95% CI: -0.75 to -0.31; p < 0.00001) and hemoglobin A1c (HbA1c) levels (SMD:-0.36; 95% CI:-0.59 to -0.12; p = 0.003) compared to placebo.”
BMC Endocr Disord 2025 · PMID 40999397
“Supplementation with carnosine or β-alanine may reduce fasting glucose, HbA1c, and HOMA-IR in humans and rodents, and fasting insulin in humans; both compounds show potential as therapeutics to improve glycemic control and insulin resistance.”
Adv Nutr 2021 · PMID 34333586
“Carnosine supplementation decreased blood glucose at 90 min (-1.31 mmol/L; p = 0.02) and 120 min (-1.60 mmol/L, p = 0.02) and total glucose area under the curve (-3.30 mmol/L; p = 0.04) following an oral glucose tolerance test.”
Nutr Metab Cardiovasc Dis 2023 · PMID 38172006
“An increase in fasting insulin and insulin resistance was hampered in individuals receiving carnosine compared to placebo, and this remained significant after adjustment for age, sex, and change in body weight (P = 0.02, P = 0.04, respectively).”
Obesity (Silver Spring) 2016 · PMID 27040154

Research describes the active mechanism and is not a claim about this specific product.

Educational information, not medical advice. This product is not intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if pregnant, nursing, or taking medication.

More in Nutraceuticals & Cellular Energizers

Omega-3 EPA/DHA Fish Oil

Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…

Creatine Monohydrate

Across meta-analyses and randomized trials, creatine monohydrate combined with…

Astaxanthin Softgels

In humans, randomized trials and meta-analyses most consistently show that astaxanthin…

Zinc Picolinate

Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…

See all Nutraceuticals & Cellular Energizers →

FAQ

Does Carnosine have scientific evidence?

Yes — its active compound is linked to 24 peer-reviewed studies, summarized and cited above.

Where can I buy Carnosine?

You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.

Is Carnosine safe?

Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.